DRD2 rs17601612: What Your Genotype Means for Sleep Patterns
The rs17601612 variant is a common genetic change located within the DRD2 gene. Research has identified this variant as having a suggestive association with sleep duration and the time it takes to fall asleep, known as sleep latency.
What each genotype means
Associated with shorter sleep
Research indicates that the C allele of this variant is associated with shorter habitual sleep duration. This variant has also shown a suggestive association with sleep latency, which refers to the time it takes to fall asleep. These findings are based on population-level statistical associations and do not predict individual sleep patterns.
This is a common variant found across multiple ancestral groups, though specific genotype frequencies vary by population.
Intermediate sleep duration profile
Carriers of this genotype possess one copy of each allele, representing an intermediate genetic profile regarding the DRD2 variant's association with sleep duration. While the C allele has been linked to shorter sleep duration in research studies, the overall impact of this specific combination remains suggestive rather than definitive. Sleep habits are influenced by a complex interplay of many genetic and environmental factors.
This is a common variant found across multiple ancestral groups, though specific genotype frequencies vary by population.
Associated with longer sleep
The G allele is the alternative to the C allele, which has been statistically linked to shorter sleep duration in large-scale studies. Individuals with this genotype may have a different genetic predisposition regarding sleep duration compared to those carrying the C allele. These associations are based on population averages and should not be used to infer personal sleep health or diagnose sleep disorders.
This is a common variant found across multiple ancestral groups, though specific genotype frequencies vary by population.
Understanding the rs17601612 Variant
The rs17601612 variant is a single nucleotide polymorphism (SNP) located within the DRD2 gene. In genetics, a SNP represents a variation at a single position in the DNA sequence among individuals. This specific variant has been the subject of scientific investigation due to its potential role in regulating physiological processes. Researchers identify such variants by their unique reference SNP ID (rsID), which serves as a standardized label for cataloging genetic data across global databases. Because this variant is located within a gene known for its role in brain signaling, scientists have focused on how it might influence behavioral and neurological traits, including those related to rest and wakefulness.
The Role of the DRD2 Gene
The DRD2 gene provides instructions for making the dopamine D2 receptor. Dopamine is a critical neurotransmitter that acts as a chemical messenger in the brain, facilitating communication between nerve cells. The D2 receptor is essential for various brain functions, including the regulation of movement, motivation, reward, and the sleep-wake cycle. By modulating how the brain responds to dopamine, the DRD2 gene influences a wide array of biological pathways. Because dopamine signaling is so fundamental to human physiology, variations in the DRD2 gene are frequently studied in the context of both psychiatric health and basic physiological traits like sleep patterns.
Research Associations and Evidence Strength
Scientific studies, including those conducted by the Candidate Gene Association Resource (CARe) consortium, have identified a significant association between rs17601612 and self-reported habitual sleep duration. Furthermore, exploratory research has observed a suggestive association between this variant and polysomnographically determined sleep latency, which measures the time it takes for an individual to transition from full wakefulness to sleep. It is important to note that while these associations are statistically significant in large cohorts, the evidence is considered moderate. Genetic associations are complex, and sleep patterns are influenced by a vast array of environmental, lifestyle, and polygenic factors. Therefore, this variant should be viewed as one small piece of a much larger, intricate biological puzzle rather than a definitive predictor of sleep behavior.
Population Frequency
The rs17601612 variant is classified as a common variant, meaning it appears frequently across diverse human populations. Research involving multi-ethnic samples—including individuals of African, Asian, European, and Hispanic American ancestry—has confirmed its presence across these groups. Because it is common, many people carry one or more copies of the variant alleles. The widespread nature of this SNP allows researchers to study its effects across different genetic backgrounds, though the specific impact of the variant can sometimes vary depending on the ancestral context and the presence of other interacting genetic factors.
Interpreting Your Genetic Information
Information regarding genetic variants like rs17601612 is intended for educational purposes and should not be used for medical diagnosis or to guide personal health decisions. While genetic research provides fascinating insights into human biology, it cannot account for the complex interplay of environment, diet, and individual health history that shapes your sleep quality. If you have concerns about your sleep patterns, such as chronic difficulty falling asleep or persistent fatigue, it is essential to consult with a qualified healthcare professional or a sleep specialist. They can provide a comprehensive evaluation and discuss evidence-based strategies for improving your sleep health. Never make changes to your lifestyle or medical regimen based solely on genetic data without professional guidance.
How common is this variant?
The rs17601612 variant is a common genetic marker found across diverse global populations, including individuals of African, Asian, European, and Hispanic American ancestry.
Frequently asked questions
Can this genetic variant diagnose a sleep disorder?
No, this variant cannot diagnose any sleep disorder. Genetic associations are statistical findings in large groups and do not provide a medical diagnosis for an individual.
Does having this variant mean I will have trouble sleeping?
Not necessarily. While the variant is associated with sleep latency in research studies, sleep is influenced by many factors, including environment, stress, and overall health, which are often more impactful than a single genetic variant.
Should I change my sleep habits based on my genotype?
You should not change your health habits based on this information. If you are concerned about your sleep, please speak with a doctor or a sleep specialist to discuss your specific needs.
Is this variant related to schizophrenia?
Some research has noted that the lead DRD2 signal is associated with schizophrenia in separate studies. However, this does not mean that carrying the rs17601612 variant causes or predicts the development of psychiatric conditions.
Sources & further reading
Educational information only, last refreshed 9/21/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs17601612?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in DRD2
This SNP in the DRD2 gene is frequently studied in the context of psychiatric genetics, particularly regarding dopamine receptor expression and schizophrenia risk.
This variant has been studied for its association with schizophrenia and dopaminergic signaling.
The TaqIB polymorphism in the DRD2 gene is associated with dopamine receptor density and various behavioral and reward-related traits.
The DRD2 TaqIB variant modulates dopamine D2 receptor density and has been investigated for associations with addiction susceptibility and antipsychotic response.
A synonymous coding variant in exon 7 of DRD2 that affects mRNA stability, translation kinetics, and dopamine-related working memory and reward phenotypes.
Known as the DRD2 TaqID polymorphism, this variant alters D2 dopamine receptor gene structure and is implicated in altered striatal dopamine functioning and substance use behavior.